About this event

  • Date and time Wed 1 Sep 2021 from 8:30am to 5:40pm
  • Location Royal Society of Medicine
  • Organised by Surgery, Coloproctology

Can't make it to London for this event?  You can now live stream this meeting from anywhere. All you need is a good internet connection. Click here to book the live stream.

At this meeting, a multidisciplinary faculty of top experts will provide state of the art lectures on current and emerging treatments for early rectal cancer.

You will learn about less aggressive treatments and stoma avoidance, with a focus on papillon radiotherapy, get updates on clinical trials, hear a patient perspective as part of the main programme, and will be able to discuss individual cases with national and international experts.

This event will educate, inform and influence professionals caring for patients with rectal cancer on the newer options available for the treatment of early tumours, taking into account patient perspectives and the provision of specialist services in the UK and abroad. Author Mark Davis will share his experience as a patient and a multidisciplinary audience will be part of panel discussions on the topics. 

Topics include:

  • To inform the audience about the current status of "Watch and Wait" strategy after (chemo) radiotherapy for early rectal cancer - both in the UK and world wide.
  • To educate multidisciplinary team members including (but not exclusively) surgeons, oncologists, cancer nurses, pathologists and radiologists about the possibility of rectal preservation and stoma avoidance when treating early rectal cancer.
  • To gain the patient perspective on this difficult area of decision making in cancer practice.
  • To understand the influence of the Bowel Screening services on downward stage migration leading to increased diagnosis of earlier rectal cancer, and hence the need for less aggressive treatments.

We would like to thank our sponsors Ariane Medical Systems, Clatterbridge Cancer Centre, Clatterbridge Private Clinic, David Andrew Research Trust 43 (DART 43), SurgEase Innovations and Synmed for their support of this meeting. Please note that the scientific programme and content has not been influenced in any way by the sponsors.

Join in the conversation online

Follow us on Twitter: @RoySocMed


View the programme

Registration, tea and coffee
Welcome and introduction

Professor Neil Mortensen, President, Royal College of Surgeons of England

Session one: Early rectal cancer - options to consider

Chairs: Professor Neil Mortensen and Professor Jean-Pierre GERARD, Radiation Oncologist, Centre Antoine Lacassagne

Surgery is the standard of care

Miss Rachel Hargest, Clinical Senior Lecturer in Colorectal Surgery, Cardiff University

When not to operate

Professor Richard (Bill) Heald, Chairman, Colorectal Cancer Programme, Champalimaud Institute and Founder, Pelican Cancer Foundation

Contact X-ray brachytherapy - who, how and when?

Professor Arthur Sun Myint, Lead Clinician (Papillon), Papillon Suite, Clatterbridge Cancer Centre

Watch and wait is an option

Dr Brechtje A Grotenhuis, Surgical Oncologist, Netherlands Cancer Institute

Panel discussion
Tea and coffee break

Session two: Early rectal cancer - options in practice

Chairs: Miss Rachel Hargest and Professor Simon Gollins, Consultant Clinical Oncologist, North Wales Cancer Treatment Centre 

My journey to wait and watch – is it safe?

Mr Shakil Ahmed, Consultant Colorectal Surgeon and Honorary Associate Professor, Liverpool University Hospital NHS Foundation Trust

TEMS is better for early tumour

Professor Chris Cunningham, Colorectal Surgeon, Oxford University Hospitals NHS Foundation Trust

Salvage surgery

Mr Ian Jenkins, Consultant Colorectal Surgeon, St Mark’s Hospital

Can we afford to "watch and wait”?

Mr Chris Rao, Colorectal Fellow, Barking, Havering and Redbridge University Hospitals NHS Trust

Dose escalation in radiotherapy

Dr Ane Appelt, Associate Professor, University of Leeds and St James’s University Hospital

Less is sometimes more

Mark Davies, Patient, Ariane Medical

Panel discussion

Session three: Early rectal cancer cases

Chair: Professor Arthur Sun Myint

MDT case one

Dr Alex Stewart, Consultant Clinical Oncologist, Royal Surrey County Hospital and Honorary Senior University of Surrey

Contact radiotherapy cases

Mr Iain Hunter, Consultant Surgeon, Hull University Teaching Hospitals Trust

An illustrative example of the use of contact radiotherapy in rectal cancer - case discussion

Dr Raj Sripadam, Consultant Clinical Oncologist, Clatterbridge Cancer Centre

MDT case four

Mr Michael Davies, Consultant Colorectal Surgeon, University Hospital of Wales

MDT case five

Dr Jeltsje S Cnossen, Radiation Oncologist, Catharina Hospital

Tea and coffee break

Session four: Clinical trials in early rectal cancer

Chair: Professor Arthur Sun Myint

OPERA trial

Professor Jean-Pierre GERARD

Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC)? an international, multicentre, rolling phase II/III partially randomised patient preference trial

Mr Simon Bach, Consultant Colorectal Surgeon, Queen Elizabeth Hospital Birmingham


Professor Simon Gollins

Panel discussion
Closing remarks

Professor Arthur Sun Myint and Miss Rachel Hargest



Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Man searching computer

Join the RSM and get free access to digital learning resources

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy free access to a wealth of online  resources, including 5,000 subscription and open access e-journals, 2,000 e-books and 5 key medical databases, to support your clinical decision-making and research.

Become a member

Disclaimer: All views expressed at this event are of the speakers themselves and not of the RSM nor the speaker's organisations.

Registration for this event will close at 12:00am on Tuesday 31 August 2021Late registrations will not be accepted.

This event will be recorded and stored by the Royal Society of Medicine and may be  distributed  in future on various internet channels.